Kymera Therapeutics (KYMR) has an average rating of buy and mean price target of $124.19, according to analysts polled by FactSet.
What else is happening in Research?
Research
Roth Capital Upgrades Comstock Resources to Neutral From Sell, $13 Price Target
Comstock Resources (CRK) has an average rating of hold and mean price target of $20.12, according to analysts polled by FactSet.Price: $12.94, Change: $-0.75, Percent Change: -5.48%
$CRK
Research
BofA Downgrades Weyerhaeuser to Neutral From Buy, Price Target is $26
Weyerhaeuser (WY) has an average rating of overweight and mean price target of $31.18, according to analysts polled by FactSet.Price: $23.53, Change: $+1.03, Percent Change: +4.58%
$WY
Research
Raymond James Upgrades Weyerhaeuser to Strong Buy From Outperform, Price Target is $30
Weyerhaeuser (WY) has an average rating of overweight and mean price target of $31.18, according to analysts polled by FactSet.Price: $23.53, Change: $+1.03, Percent Change: +4.58%
$WY